$6.88 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 344 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 6.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TESLA INnote2 | $36,835,000,000 | -2.3% | 30,000,000 | 0.0% | 0.54% | -13.3% | ||
| AEGERIONnote2 | $20,669,000,000 | -0.6% | 26,000,000 | 0.0% | 0.30% | -11.8% | ||
| TPGHU | TPG PACEunit9 | $10,300,000,000 | +0.4% | 1,000,000 | 0.0% | 0.15% | -10.7% | |
| GOGO | GOGO INC | $8,073,000,000 | +2.4% | 683,550 | 0.0% | 0.12% | -9.3% | |
| OREXIGENnote2 | $3,000,000,000 | 0.0% | 7,500,000 | 0.0% | 0.04% | -10.2% | ||
| OREXIGENnote2 | $3,000,000,000 | 0.0% | 7,500,000 | 0.0% | 0.04% | -10.2% | ||
| BIOMARINnote0 | $1,121,000,000 | +0.7% | 1,000,000 | 0.0% | 0.02% | -11.1% | ||
| ILLUMINAnote6 | $1,060,000,000 | +4.4% | 1,000,000 | 0.0% | 0.02% | -11.8% | ||
| NUANCE Cdbcv1 | $941,000,000 | -2.9% | 1,000,000 | 0.0% | 0.01% | -12.5% | ||
| TWITTERnote0 | $950,000,000 | +0.1% | 1,000,000 | 0.0% | 0.01% | -12.5% | ||
| ACORDA Tnote1 | $908,000,000 | +5.2% | 1,000,000 | 0.0% | 0.01% | -7.1% | ||
| INTERCEPnote3 | $778,000,000 | -20.4% | 1,000,000 | 0.0% | 0.01% | -31.2% | ||
| GCVRZ | SANOFIright | $446,000,000 | -5.1% | 1,238,077 | 0.0% | 0.01% | -25.0% | |
| PLX | PROTALIX | $188,000,000 | -30.9% | 324,479 | 0.0% | 0.00% | -25.0% | |
| TWX | TIME WARput | $61,000,000 | -21.8% | 1,735,500 | 0.0% | 0.00% | 0.0% | |
| CYHHZ | COMMUNITright | $59,000,000 | -40.4% | 5,055,677 | 0.0% | 0.00% | -50.0% | |
| OREXQ | OREXIGEN | $0 | – | 33,333 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| META PLATF | 36 | Q3 2023 | 2.3% |
| SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
| ACTIVISION | 29 | Q3 2023 | 71.3% |
| AMAZON COM | 29 | Q3 2023 | 0.8% |
| GAMING & L | 29 | Q3 2023 | 0.8% |
| SPDR S&P | 29 | Q1 2023 | 0.1% |
| DISNEY W | 28 | Q3 2021 | 2.0% |
| POST HLD | 27 | Q2 2020 | 1.8% |
| GENERAL | 27 | Q3 2022 | 1.4% |
| CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
| MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
| New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
| Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
| ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
| Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
| Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
| GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
| GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-06-06 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.